InsidersTradesSigma
Follow the 方盛制药 share price and the full insider trade history of the company, a listed equity based in China. Shares trade on the CN market, under the oversight of SSE / SZSE (CSRC). Operating in the Health Care sector, 方盛制药 has published 10 public disclosures. Market capitalisation: €4.1bn. The latest transaction was filed on 13 May 2025 (Purchase). Among the most active insiders: 何仕. The full history is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
10 of 10 declarations
Fangsheng Pharmaceutical es una empresa que opera en el sector de la salud y farmacéutico, cotiza en la Bolsa de Shanghái. Se enfoca en la investigación, desarrollo y producción de medicamentos innovadores.